Cargando…
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
INTRODUCTION: Coronavirus Disease 2019 (COVID-19) is an ongoing public health crisis that has sickened or precipitated death in millions. The etiologic agent of COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), infects the intestinal epithelium, and can induce GI symptoms simil...
Autores principales: | Alvarado, David M., Son, Juhee, Thackray, Larissa B., Diamond, Michael S., Ding, Siyuan, Ciorba, Matthew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351781/ https://www.ncbi.nlm.nih.gov/pubmed/34373857 http://dx.doi.org/10.1101/2021.07.23.453393 |
Ejemplares similares
-
Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2022) -
Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2021) -
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
por: Christophi, George P, et al.
Publicado: (2016) -
Adding Fuel to the Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection
por: Antia, Avan, et al.
Publicado: (2022) -
Mesalamine-Induced Myocarditis
por: Merceron, Olivier, et al.
Publicado: (2010)